ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)

By  

THE PROSTATE, Vol. 270-4137, Iss. 15, 2015-11 ,pp. : 1677-1681

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comprehensive analysis of polymorphic variants in steroid hormone and insulin‐like growth factor‐1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 6, 2018-03 ,pp. : 1182-1188

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating vitamin D, vitamin D–related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 1949-1956

John Wiley & Sons Inc

Access to resources Recommend Favorite

ABO blood group, hypercoagulability, and cardiovascular and cancer risk

By Franchini Massimo   Favaloro Emmanuel J.   Targher Giovanni   Lippi Giuseppe  

Critical Reviews in Clinical Laboratory Sciences, Vol. 49, Iss. 4, 2012-08 ,pp. : 137-149

Informa Healthcare

Access to resources Recommend Favorite

Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study

By  

THE PROSTATE, Vol. 75, Iss. 13, 2015-09 ,pp. : 1384-1393

John Wiley & Sons Inc

Access to resources Recommend Favorite